MPT Product Development Database

This database includes MPT products that are currently in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Please note there are other MPT candidates not listed that may move forward pending funding. Click here to learn more about the inclusion criteria and information update methodology.
Click on the table for MPT products in the development pipeline by indication combination.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
Hormonal/Non-HormonalDelivery RouteDelivery MethodDevelopment Stage
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
Key Word Search   

24 product(s) found

mAb 2C7 + TDF IVR

MPT in Development

Development Stage:
Preclinical – Advanced (Pre2)
Delivery Route & Method:
Topical - Intravaginal Ring (IVR)
Mechanism of Action:
mAb 2C7 mediates complement-dependent killing of Neisseria gonorrhoeae
  • MassBiologics
  • Oak Crest Institute of Science
  • Planet Biotechnology, Inc.
  • University of Massachusetts
  • Funding:
  • Nat. Institute Allergy & Infect. Diseases (NIAID)
  • Funding Mechanism:
    NIAID: R33
    Active Ingredient:
  • Monoclonal Antibodies
  • Tenofovir Disoproxil Fumarate (TDF)
  • Product Indications:
  • Gonorrhea
  • HIV
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    © Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.